Despite the needed additional studies, in the present work, the overexpression of TFR-1 was highlighted for the first time in feline mammary carcinoma, and the application of drug-loaded HFn nanoparticles was identified as a potentially useful treatment for this common malignancy in this animal species. The gene discussed is TFRC; the disease is breast carcinoma.